Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells

Journal of Immunology

Volumn 184, Issue 8, 2010, Pages 4557-4567

  Allen, Carl E ^a,b   Li, Liunan ^a   Peters, Tricia L ^b   Leung, Hon Chiu Eastwood ^a,b   Yu, Alexander ^a   Man, Tsz Kwong ^a,b   Gurusiddappa, Sivashankarappa ^a   Phillips, Michelle T ^a   Hicks, M John ^b   Gaikwad, Amos ^a   Merad, Miriam ^c   McClain, Kenneth L ^a,b  

^a TEXAS CHILDREN S CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LANGERIN; OSTEOPONTIN; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; CD207 PROTEIN, HUMAN; CD3 ANTIGEN; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN;

ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; MYELOID DENDRITIC CELL; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ADOLESCENT; BIOSYNTHESIS; CHILD; COMPARATIVE STUDY; CYTOLOGY; DNA MICROARRAY; EPIDERMIS; GENETICS; IMMUNOLOGY; INFANT; METABOLISM; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD3; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; EPIDERMIS; GENE EXPRESSION PROFILING; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77952765452     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902336     Document Type: Article

References (80)

1. Carstensen, H., and K. Ornvold. 1993. [Langerhans-cell histiocytosis (histiocytosis X) in children]. Ugeskr. Laeger 155: 1779-1783.
2. Aricò, M., M. Girschikofsky, T. Généreau, C. Klersy, K. McClain, N. Grois, J. F. Emile, E. Lukina, E. De Juli, and C. Danesino; Report from the International Registry of the Histiocyte Society. 2003. Langerhans cell histiocytosis in adults. Eur. J. Cancer 39: 2341-2348.
3. Arceci, R. J. 1999. The histiocytoses: the fall of the Tower of Babel. Eur. J. Cancer 35: 747-767, discussion 767-769.
4. McClain, K. L., Y. Natkunam, and S. H. Swerdlow. 2004. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program) 283-296.
5. Gadner, H., N. Grois, U. Pötschger, M. Minkov, M. Aricò, J. Braier, V. Broadbent, J. Donadieu, J. I. Henter, R. McCarter, and S. Ladisch; Histiocyte Society. 2008. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111: 2556-2562.
6. Gadner, H., N. Grois, M. Arico, V. Broadbent, A. Ceci, A. Jakobson, D. Komp, J. Michaelis, S. Nicholson, U. Pötschger, et al; and Histiocyte Society. 2001. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J. Pediatr. 138: 728-734.
7. Allen, C. E., and K. L. McClain. 2007. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs Today (Barc) 43: 627-643. (Pubitemid 350004868)
8. Egeler, R. M., N. E. Annels, and P. C. Hogendoorn. 2004. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation. Pediatr. Blood Cancer 42: 401-403.
9. Fadeel, B., and J. I. Henter. 2003. Langerhans-cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol. 24: 409-410, author reply 410-411.
10. Laman, J. D., P. J. Leenen, N. E. Annels, P. C. Hogendoorn, and R. M. Egeler. 2003. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol. 24: 190-196.
11. Nezelof, C., F. Basset, and M. F. Rousseau. 1973. Histiocytosis X histogenic arguments for a Langerhans cell origin. Biomedicine 18: 365-371.
12. Willman, C. L., and K. L. McClain. 1998. An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am. 12: 407-416.
13. Favara, B. E., and A. Steele. 1997. Langerhans cell histiocytosis of lymph nodes: amorphological assessment of 43 biopsies. Pediatr. Pathol. Lab. Med. 17: 769-787.
14. Schroeder, A., O. Mueller, S. Stocker, R. Salowsky, M. Leiber, M. Gassmann, S. Lightfoot, W. Menzel, M. Granzow, and T. Ragg. 2006. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 7: 3.
15. Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5: R80.
16. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
17. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, et al. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
18. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
19. Pradervand, S., A. Paillusson, J. Thomas, J. Weber, P. Wirapati, O. Hagenbüchle, and K. Harshman. 2008. Affymetrix Whole-Transcript Human Gene 1.0 STarray is highly concordant with standard 39 expression arrays. Biotechniques 44: 759-762. (Pubitemid 351839144)
20. Singh, R., R. J. Maganti, S. V. Jabba, M. Wang, G. Deng, J. D. Heath, N. Kurn, and P. Wangemann. 2005. Microarray-based comparison of three amplification methods for nanogram amounts of total RNA. Am. J. Physiol. Cell Physiol. 288: C1179-C1189.
21. Bechan, G. I., R. M. Egeler, and R. J. Arceci. 2006. Biology of Langerhans cells and Langerhans cell histiocytosis. Int. Rev. Cytol. 254: 1-43.
22. Coury, F., N. Annels, A. Rivollier, S. Olsson, A. Santoro, C. Speziani, O. Azocar, M. Flacher, S. Djebali, J. Tebib, et al. 2008. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 14: 81-87.
23. de Graaf, J. H., R. Y. Tamminga, A. Dam-Meiring, W. A. Kamps, and W. Timens. 1996. The presence of cytokines in Langerhans' cell histiocytosis. J. Pathol. 180: 400-406. (Pubitemid 27014078)
24. Egeler, R. M., B. E. Favara, M. van Meurs, J. D. Laman, and E. Claassen. 1999. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94: 4195-4201.
25. de Graaf, J. H., R. Y. Tamminga, W. A. Kamps, and W. Timens. 1995. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. Am. J. Pathol. 147: 1161-1171.
26. Geissmann, F., J. F. Emile, P. Andry, C. Thomas, S. Fraitag, Y. De Prost, and N. Brousse. 1997. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J. Pathol. 181: 301-304. (Pubitemid 27156843)
27. da Costa, C. E., N. E. Annels, C. M. Faaij, R. G. Forsyth, P. C. Hogendoorn, and R. M. Egeler. 2005. Presence of osteoclast-likemultinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J. Exp. Med. 201: 687-693.
28. Hayashi, T., W. L. Rush, W. D. Travis, L. A. Liotta, W. G. Stetler-Stevenson, and V. J. Ferrans. 1997. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch. Pathol. Lab. Med. 121: 930-937.
29. Amir, G., and M. Weintraub. 2008. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis. Pediatr. Blood Cancer 50: 304-307.
30. Schouten, B., R. M. Egeler, P. J. Leenen, A. H. Taminiau, L. J. van den Broek, and P. C. Hogendoorn. 2002. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24: 727-732.
31. Bank, M. I., C. Gudbrand, P. Rengtved, H. Carstensen, B. Fadeel, J. I. Henter, and B. L. Petersen. 2005. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 27: 301-306.
32. Annels, N. E., C. E. Da Costa, F. A. Prins, A. Willemze, P. C. Hogendoorn, and R. M. Egeler. 2003. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J. Exp. Med. 197: 1385-1390.
33. de Graaf, J. H., R. Y. Tamminga, W. A. Kamps, and W. Timens. 1994. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am. J. Pathol. 144: 466-472.
34. Rust, R., J. Kluiver, L. Visser, G. Harms, T. Blokzijl, W. Kamps, S. Poppema, and A. van den Berg. 2006. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis. J. Pathol. 209: 474-483. (Pubitemid 44194562)
35. Vulcano, M., C. Albanesi, A. Stoppacciaro, R. Bagnati, G. D'Amico, S. Struyf, P. Transidico, R. Bonecchi, A. Del Prete, P. Allavena, et al. 2001. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31: 812-822.
36. Fleming, M. D., J. L. Pinkus, M. V. Fournier, S. W. Alexander, C. Tam, M. Loda, S. E. Sallan, K. E. Nichols, D. F. Carpentieri, G. S. Pinkus, and B. J. Rollins. 2003. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 101: 2473-2475. (Pubitemid 36857600)
37. Emile, J. F., S. Fraitag, M. Leborgne, Y. de Prost, and N. Brousse. 1994. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J. Pathol. 174: 71-76. (Pubitemid 24318449)
38. Ornvold, K., E. Ralfkiaer, and H. Carstensen. 1990. Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x). Virchows Arch. A Pathol. Anat. Histopathol. 416: 403-410.
39. Ruco, L. P., D. Remotti, F. Monardo, S. Uccini, M. L. Cristiani, A. Modesti, and C. D. Baroni. 1988. Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage. Virchows Arch. A Pathol. Anat. Histopathol. 413: 239-247.
40. Rolland, A., L. Guyon, M. Gill, Y. H. Cai, J. Banchereau, K. McClain, and A. K. Palucka. 2005. Increased blood myeloid dendritic cells and dendritic cellpoietins in Langerhans cell histiocytosis. J. Immunol. 174: 3067-3071. (Pubitemid 40279728)
41. Geissmann, F., Y. Lepelletier, S. Fraitag, J. Valladeau, C. Bodemer, M. Debré, M. Leborgne, S. Saeland, and N. Brousse. 2001. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97: 1241-1248. (Pubitemid 32183745)
42. Hage, C., C. L. Willman, B. E. Favara, and P. G. Isaacson. 1993. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction. Hum. Pathol. 24: 840-845.
43. Santegoets, S. J., S. Gibbs, K. Kroeze, R. van de Ven, R. J. Scheper, C. A. Borrebaeck, T. D. de Gruijl, and M. Lindstedt. 2008. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J. Leukoc. Biol. 84: 143-151.
44. Egeler, R. M., B. E. Favara, J. D. Laman, and E. Claassen. 2000. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Cancer 36: 2105-2110.
45. Misery, L., N. Rougier, B. Crestani, M. Faure, A. Claudy, D. Schmitt, and C. Vincent. 1999. Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis. Clin. Exp. Immunol. 117: 177-182.
46. Soilleux, E. J., and N. Coleman. 2001. Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN. Blood 98: 1987-1988.
47. Simonitsch, I., C. W. Kopp, I. Mosberger, B. Volc-Platzer, and T. Radaszkiewicz. 1996. Expression of the monoclonal antibody HECA-452 defined E-selectin ligands in Langerhans cell histiocytosis. Virchows Arch. 427: 477-481. (Pubitemid 126828178)
48. Abdelatif, O. M., F. W. Chandler, C. G. Pantazis, and B. S. McGuire. 1990. Enhanced expression of c-myc and H-ras oncogenes in Letterer-Siwe disease. A sequential study using colorimetric in situ hybridization. Arch. Pathol. Lab. Med. 114: 1254-1260.
49. Petersen, B. L., P. Rengtved, M. I. Bank, and H. Carstensen. 2003. High expression of markers of apoptosis in Langerhans cell histiocytosis. Histopathology 42: 186-193.
50. Jaffe, R., D. DeVaughn, and E. Langhoff. 1998. Fascin and the differential diagnosis of childhood histiocytic lesions. Pediatr. Dev. Pathol. 1: 216-221.
51. Pinkus, G. S., M. A. Lones, F. Matsumura, S. Yamashiro, J. W. Said, and J. L. Pinkus. 2002. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am. J. Clin. Pathol. 118: 335-343.
52. Emile, J. F., E. Tartour, L. Brugières, J. Donadieu, F. LeDeist, I. Charnoz, A. Fischer, W. H. Fridman, and N. Brousse. 1994. Detection of GM-CSF in the sera of children with Langerhans' cell histiocytosis. Pediatr. Allergy Immunol. 5: 162-163.
53. Emile, J. F., S. Fraitag, P. Andry, M. Leborgne, A. Lellouch-Tubiana, and N. Brousse. 1995. Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells. Virchows Arch. 427: 125-129.
54. Bechan, G. I., A. K. Meeker, A. M. De Marzo, F. Racke, R. Jaffe, E. Sugar, and R. J. Arceci. 2008. Telomere length shortening in Langerhans cell histiocytosis. Br. J. Haematol. 140: 420-428.
55. da Costa, C. E., R. M. Egeler, M. Hoogeboom, K. Szuhai, R. G. Forsyth, M. Niesters, R. R. de Krijger, A. Tazi, P. C. Hogendoorn, and N. E. Annels. 2007. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease. J. Pathol. 212: 188-197.
56. Senechal, B., G. Elain, E. Jeziorski, V. Grondin, N. Patey-Mariaud de Serre, F. Jaubert, K. Beldjord, A. Lellouch, C. Glorion, M. Zerah, et al. 2007. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 4: e253. (Pubitemid 47358173)
57. Rosso, D. A., M. F. Ripoli, A. Roy, R. A. Diez, M. E. Zelazko, and J. L. Braier. 2003. Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 25: 480-483.
58. Ishii, R., A. Morimoto, S. Ikushima, T. Sugimoto, K. Asami, F. Bessho, K. Kudo, Y. Tsunematu, J. Fujimoto, and S. Imashuku. 2006. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis. Pediatr. Blood Cancer 47: 194-199. (Pubitemid 44025252)
59. Rosso, D. A., A. Roy, M. Zelazko, and J. L. Braier. 2002. Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. Br. J. Haematol. 117: 54-58.
60. Bank, M. I., P. Rengtved, H. Carstensen, and B. L. Petersen. 2002. p53 expression in biopsies from children with Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24: 733-736.
61. Weintraub, M., K. G. Bhatia, R. S. Chandra, I. T. Magrath, and S. Ladisch. 1998. p53 expression in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 20: 12-17.
62. Nakajima, T., S. Watanabe, Y. Sato, Y. Shimosato, M. Motoi, and K. Lennert. 1982. S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann 73: 429-432. (Pubitemid 12097113)
63. Wu, W. S., and K. L. McClain. 1997. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J. Interferon Cytokine Res. 17: 631-635.
64. Trzpis, M., P. M. McLaughlin, L. M. de Leij, and M. C. Harmsen. 2007. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am. J. Pathol. 171: 386-395.
65. Hildebrandt, T., J. Preiherr, N. Tarbé, S. Klostermann, G. N. Van Muijen, and U. H. Weidle. 2000. Identification of THW, a putative new tumor suppressor gene. Anticancer Res. 20(5A): 2801-2809.
66. Ihrie, R. A., M. R. Marques, B. T. Nguyen, J. S. Horner, C. Papazoglu, R. T. Bronson, A. A. Mills, and L. D. Attardi. 2005. Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856.
67. Guan, K. L., and E. Butch. 1995. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogenactivated protein kinase. J. Biol. Chem. 270: 7197-7203.
68. McClain, K. L., P. Laud, W. S. Wu, and M. S. Pollack. 2003. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med. Pediatr. Oncol. 41: 502-507.
69. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
70. Valladeau, J., V. Duvert-Frances, J. J. Pin, C. Dezutter-Dambuyant, C. Vincent, C. Massacrier, J. Vincent, K. Yoneda, J. Banchereau, C. Caux, et al. 1999. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29: 2695-2704.
71. Merad, M., F. Ginhoux, and M. Collin. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8: 935-947.
72. Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, M. Loubeau, X. M. Dai, E. R. Stanley, G. J. Randolph, and M. Merad. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7: 265-273.
73. Wang, K. X., and D. T. Denhardt. 2008. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19: 333-345.
74. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
75. Rodrigues, L. R., J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mänsson. 2007. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16: 1087-1097.
76. Lepelletier, Y., S. Smaniotto, R. Hadj-Slimane, D. M. Villa-Verde, A. C. Nogueira, M. Dardenne, O. Hermine, and W. Savino. 2007. Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions. Proc. Natl. Acad. Sci. USA 104: 5545-5550.
77. Tordjman, R., Y. Lepelletier, V. Lemarchandel, M. Cambot, P. Gaulard, O. Hermine, and P. H. Roméo. 2002. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3: 477-482.
78. Aurrand-Lions, M., F. Galland, H. Bazin, V. M. Zakharyev, B. A. Imhof, and P. Naquet. 1996. Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity 5: 391-405.
79. Meghari, S., C. Berruyer, H. Lepidi, F. Galland, P. Naquet, and J. L. Mege. 2007. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. Eur. J. Immunol. 37: 24-32.
80. Allen, C. E., and K. L. McClain. 2009. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat. Med. 15: 483-484, author reply 484-485.